Related references
Note: Only part of the references are listed.Analysis of the BRAFV600E mutation in 19 cases of Langerhans cell histiocytosis in Japan
Yuya Sasaki et al.
HEMATOLOGICAL ONCOLOGY (2017)
Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors
Rashmi S. Goswami et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
J.-F. Emile et al.
BLOOD (2016)
Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis
Rikhia Chakraborty et al.
BLOOD (2016)
BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases
Khaled Alayed et al.
HUMAN PATHOLOGY (2016)
BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy
Sebastien Heritier et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature
Muhammad Ahmed Farooq Anwar et al.
JOURNAL OF SURGICAL RESEARCH (2016)
Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions
Leomar Y. Ballester et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2016)
Comparison of Next-generation Sequencing Mutation Profiling With BRAF and IDH1 Mutation-specific Immunohistochemistry
Kausar J. Jabbar et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR
Anna L. Reid et al.
CLINICAL BIOCHEMISTRY (2015)
MAP2K1 and MAP3K1 Mutations in Langerhans Cell Histiocytosis
David S. Nelson et al.
GENES CHROMOSOMES & CANCER (2015)
Cell(s) of Origin of Langerhans Cell Histiocytosis
Matthew Collin et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)
BRAF V600E mutation-specific antibody: A review
Lauren L. Ritterhouse et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2015)
Analysis of Pre-Analytic Factors Affecting the Success of Clinical Next-Generation Sequencing of Solid Organ Malignancies
Hui Chen et al.
CANCERS (2015)
BRAF V600E Expression in Langerhans Cell Histiocytosis Clinical and Immunohistochemical Study on 25 Pulmonary and 54 Extrapulmonary Cases
Anja C. Roden et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Activating BRAF V600E Mutation in Aggressive Pediatric Langerhans Cell Histiocytosis Demonstration by Allele-specific PCR/Direct Sequencing and Immunohistochemistry
Gabor Mehes et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Somatic activating ARAF mutations in Langerhans cell histiocytosis
David S. Nelson et al.
BLOOD (2014)
High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis
Noah A. Brown et al.
BLOOD (2014)
Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis
Rikhia Chakraborty et al.
BLOOD (2014)
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations
Michaela Angelika Ihle et al.
BMC CANCER (2014)
Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis
Arkadiusz Gertych et al.
DIAGNOSTIC PATHOLOGY (2014)
Frequent detection of BRAFV600E mutations in histiocytic and dendritic cell neoplasms
Heounjeong Go et al.
HISTOPATHOLOGY (2014)
Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays
Kevin E. Fisher et al.
HUMAN PATHOLOGY (2014)
Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization
Shih-Fan Kuan et al.
HUMAN PATHOLOGY (2014)
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
Marie-Luise Berres et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Differentiating Skin-Limited and Multisystem Langerhans Cell Histiocytosis
Stephen J. Simko et al.
JOURNAL OF PEDIATRICS (2014)
Clinical Characteristics and Treatment Outcome of Langerhans Cell Histiocytosis: 22 Years' Experience of 154 Patients at a Single Center
Ji Won Lee et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2014)
Potential clinical implications of BRAF mutations in histiocytic proliferations
Anna-Maria Bubolz et al.
ONCOTARGET (2014)
Immunohistochemical Investigation of BRAF p.V600E Mutations in Thyroid Carcinoma Using 2 Separate BRAF Antibodies
Kevin E. Fisher et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2014)
Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients
M. Ilie et al.
ANNALS OF ONCOLOGY (2013)
Pathogenesis of Langerhans Cell Histiocytosis
Gayane Badalian-Very et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 8 (2013)
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis
Helmut Gadner et al.
BLOOD (2013)
Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma
Cheryl A. Adackapara et al.
HISTOPATHOLOGY (2013)
Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma
John K. Feller et al.
MODERN PATHOLOGY (2013)
Tumor Homogeneity between Primary and Metastatic Sites for BRAF Status in Metastatic Melanoma Determined by Immunohistochemical and Molecular Testing
Lucile Boursault et al.
PLOS ONE (2013)
A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma
Anna Richter et al.
SCIENTIFIC REPORTS (2013)
Application of a BRAF V600E Mutation-specific Antibody for the Diagnosis of Hairy Cell Leukemia
Mindaugas Andrulis et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
Felix Sahm et al.
BLOOD (2012)
Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma
Molly Yancovitz et al.
PLOS ONE (2012)
Correction: B-RAF Mutant Alleles Associated with Langerhans Cell Histiocytosis, a Granulomatous Pediatric Disease
Takeshi Satoh et al.
PLoS One (2012)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
Recurrent BRAF mutations in Langerhans cell histiocytosis
Gayane Badalian-Very et al.
BLOOD (2010)
Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders
Sean K. Lau et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Chronic inflammation: A common and important factor in the pathogenesis of neoplasia
D Schottenfeld et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2006)
Ewing's sarcoma of bone: the detection of specific transcripts in a large, consecutive series of formalin-fixed, decalcified, paraffin-embedded tissue samples using the reverse transcriptase-polymerase chain reaction
DC Mangham et al.
HISTOPATHOLOGY (2006)
Application of BIOMED-2 primers in fixed and decalcified bone marrow biopsies - Analysis of immunoglobulin H receptor rearrangements in B-cell non-Hodgkin's lymphomas
S Lassmann et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Langerhans cell histiocytosis: Current insights in a molecular age with emphasis on clinical oral and maxillofacial pathology practice
J Hicks et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2005)
Share Paper
